Abstract

Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2017 - Volume 21, Number 5

Page(s): 415

Download in electronic PDF format for $75
  • Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose Page 1

Abstract

A formulation for preparing Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • periteoneal dialysis solution
  • compounded sterile preparations
  • intraperitoneal administration

Related Categories

  • FORMULATIONS
  • STERILE PREPARATIONS
  • UROLOGY/URINARY TRACT

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2017
Pg. 415
Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose
Author(s): Allen Loyd V Jr
Jul/Aug 2007
Pg. 331
Moxifloxacin in Dianeal 1.36% Peritoneal Dialysis Solution
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 481-486
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Author(s): Allen Loyd V Jr
Jul/Aug 1999
Pg. 306
Vancomycin and Ceftazidime in Peritoneal Dialysis Solution
Author(s): Allen Loyd V Jr
Sep/Oct 2016
Pg. 399-404
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Jan/Feb 2016
Pg. 41-45
Formulation and Stability of Solutions
Author(s): Akers Michael J
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
Mar/Apr 2004
Pg. 89-94
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists
Author(s): Rahe Hank
Jul/Aug 2021
Pg. 324
Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Author(s): Allen Loyd V Jr
May/Jun 2022
Pg. 219-228
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Author(s): Allen Loyd V Jr
Sep/Oct 2015
Pg. 367-373
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries
Author(s): Guth Michael AS
Sep/Oct 2014
Pg. 414
Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 221-228
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Author(s): Allen Loyd V Jr
Jan/Feb 2022
Pg. 41-49
Sterile Basics: Compounding Sterile Preparations with Cyclodextrins
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 133-142
Accuracy Considerations in Sterile Compounding
Author(s): Akers Michael J
Mar/Apr 2016
Pg. 137-141
Formulation and Stability of Solutions
Author(s): Akers Michael J
Nov/Dec 2016
Pg. 495-500
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Author(s): Allen Loyd V Jr